QuidelOrtho to Report Third Quarter 2025 Financial Results
Get Alerts QDEL Hot Sheet
Join SI Premium – FREE
Following the release of financial results, QuidelOrtho will hold a conference call beginning at
A replay of the conference call will be available shortly after the event on the "Investor Relations" page of the Company's website under the "Events & Presentations" section.
QuidelOrtho is dedicated to advancing diagnostics to power a healthier future. For more information, please visit quidelortho.com and follow QuidelOrtho on LinkedIn, Facebook and X.
About QuidelOrtho Corporation
With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation (Nasdaq: QDEL) is a leading global provider of diagnostic solutions, delivering fast, accurate and reliable results that help improve patient outcomes – from the point of care to hospital, lab to clinic. Building on a legacy of innovation, QuidelOrtho works with healthcare providers to advance diagnostics that connect insights with solutions, defining a clearer path for informed decisions and better care.
Investor Contact:
Vice President, Investor Relations
[email protected]
Media Contact:
Senior Director, Corporate Communications
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/quidelortho-to-report-third-quarter-2025-financial-results-302591019.html
SOURCE QuidelOrtho Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- "Heavy" Rare Earths Produced by Energy Fuels Qualified for Use by Largest Permanent Magnet Manufacturer in Japan
- Trevor Donovan and Stephanie Bennett Find Love, Hope, and Forever Homes In A Christmas Rescue, World Premiere Original Film Streaming on Great American Pure Flix, November 26 Premiering on Great Ameri
- FLRT Debuts First-Ever Flavor Innovation, Apple Bottoms Up, Just in Time for Fall
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share